JPRN-UMIN000051242已完成Unknown
Physiological effects highly concentrated fine bubble water with oxygen-infused during high-altitude mountain climbing and high-intensity exercise - Physiological effects of highly concentrated fine bubble water with oxygen-infused
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The participants are not eligible to participate in the survey if they: (a) can not walk without instruments (T-cane, crutch, wheelchair etc...); (b) have some sort of injury so as to hinder exercise at the time of the survey.
研究者
相似试验
已完成
不适用
Evaluation with electrical impedance tomography (EIT) of the application of a High-Frequency Chest Wall Oscillation device to clear airway secretionsImpaired cough with tracheobronchial secretion retentionHigh-Frequency Chest Wall Oscillation (HFCWO)Respiratory - Other respiratory disorders / diseasesAcute Respiratory FailureACTRN12615001257550Federico Longhini, MD60
已完成
不适用
Examination of the effect that highly-concentrated local anesthetic cream (Emura ® cream) gives to a venipunctural pain.JPRN-UMIN000012873Department of Anesthesia and Resuscitology Shinshu University School of Medicine30
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)EUCTR2018-000462-11-ESBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10080083Term: Advanced lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-BEBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab incombination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer(NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer(NSCLC)MedDRA version: 20.0Level: LLTClassification code 10007096Term: Cancer of lungSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO250